Most Clicked StoriesMore >


CMS guidance attempts to circumvent Medicare Part D noninterference clause

PCMA SmartBrief | Oct 23, 2014

Draft guidance issued by the CMS last month would have serious implications for the ability of Medicare Part D plans to hold down costs through preferred pharmacy networks. The proposal explicitly interferes in the negotiation process between plan sponsors and pharmacies, explain Douglas Holtz-Eakin and Angela Boothe. "This will increase costs for seniors, disabled Medicare enrollees, and taxpayers," they warn. American Action Forum (10/23)


Study: Specialty drugs to account for $235B by 2018

PCMA SmartBrief | Oct 21, 2014

Mark Merritt among top lobbyists for 2014

PCMA SmartBrief | Oct 22, 2014

Study: Drug coupons stymie payers' cost-saving efforts

PCMA SmartBrief | Oct 23, 2014

Analysis: Independent drugstores participating in Medicare Part D preferred pharmacy networks

PCMA SmartBrief | Oct 21, 2014

Roche sets high price for new lung drug

PCMA SmartBrief | Oct 20, 2014

CMS solicits feedback on Part D prior authorization form for hospice drugs

PCMA SmartBrief | Oct 20, 2014

CVS Health developing "tobacco-free" pharmacy networks

PCMA SmartBrief | Oct 21, 2014

Opinion: How high prices distort the search for new drugs

PCMA SmartBrief | Oct 24, 2014

Part D deserves credit for slowdown in Medicare spending, experts say

PCMA SmartBrief | Oct 23, 2014


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more